S. Velayudhan

发表

Polymorphic Dynamics of Ribosomal Proteins′ Gene Expression during Induced Pluripotency

Sailu Yellaboina, Sreenivasulu Kurukuti, Prashanth Kumar Guthikonda, 2017 .

Gene Editing in Human Induced Pluripotent Stem Cells Using Doxycycline-Inducible CRISPR-Cas9 System.

S. Velayudhan, Vasanth Thamodaran, S. Rani, 2021, Methods in molecular biology.

Direct Generation of Immortalized Erythroid Progenitor Cell Lines from Peripheral Blood Mononuclear Cells

P. Balasubramanian, Yukio Nakamura, K. M. Mohankumar, 2021, Cells.

Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2

P. Balasubramanian, V. Mathews, P. Krishnamurthy, 2015, PloS one.

Erythroid lineage-specific lentiviral RNAi vectors suitable for molecular functional studies and therapeutic applications

P. Balasubramanian, K. M. Mohankumar, A. Srivastava, 2022, Scientific Reports.

Role of Long Non-Coding RNAs in Human-Induced Pluripotent Stem Cells Derived Megakaryocytes: A p53, HOX Antisense Intergenic RNA Myeloid 1, and miR-125b Interaction Study

S. Dahariya, Sanjeev Raghuwanshi, R. Gutti, 2022, The Journal of Pharmacology and Experimental Therapeutics.

Optimization of SARS-CoV-2 Pseudovirion Production in Lentivirus Backbone With a Novel Liposomal System

K. M. Mohankumar, M. Moorthy, A. Srivastava, 2022, Frontiers in Pharmacology.

Precise modelling and correction of a spectrum of β-thalassemic mutations in human erythroid cells by base editors

P. Balasubramanian, K. M. Mohankumar, R. Kurita, 2022, bioRxiv.

Derivation of Clinical-Grade Induced Pluripotent Stem Cell Lines from Erythroid Progenitor Cells in Xenofree Conditions.

C. Premkumar, A. Srivastava, Gurbind Singh, 2021, Methods in molecular biology.

Generation of an induced pluripotent stem cell line that mimics the disease phenotypes from a patient with Fanconi anemia by conditional complementation.

B. George, A. Srivastava, S. P. Bharathan, 2017, Stem cell research.

Identification of rare and novel deletions that cause (δβ)0‐thalassaemia and hereditary persistence of foetal haemoglobin in Indian population

M. Chandy, A. Srivastava, R. Das, 2014, European journal of haematology.

A novel deletion of β-globin promoter causing high HbA2 in an Indian population

A. Srivastava, Janakiram Rayabaram, S. Velayudhan, 2012, Haematologica.

Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide

B. George, K. Lakshmi, P. Balasubramanian, 2018, Bone Marrow Transplantation.

Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin

S. Wyman, J. Corn, P. Balasubramanian, 2022, eLife.

Identification of novel HPFH-like mutations by CRISPR base editing that elevates the expression of fetal hemoglobin

S. Wyman, J. Corn, P. Balasubramanian, 2020, bioRxiv.

Systematic evaluation of markers used for the identification of human induced pluripotent stem cells

M. D. Pratheesh, A. Srivastava, Syed Mohammed Musheer Aalam, 2017, Biology Open.

Comprehensive Analysis of microRNAs in Human Adult Erythropoiesis

Yukio Nakamura, Jyoti Singh, Janakiram Rayabaram, 2021, Cells.

Quality control guidelines for clinical-grade human induced pluripotent stem cell lines.

Jihwan Song, Alok Srivastava, Amit Chandra, 2018, Regenerative medicine.

Polymorphic dynamics of ribosomal proteins gene expression during somatic cell reprogramming and their differentiation in to specialized cells-types

Sailu Yellaboina, Sreenivasulu Kurukuti, Prashanth Kumar Guthikonda, 2017, bioRxiv.

Spectrum of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia from India with suspected resistance to imatinib-mutations are rare and have different distributions

B. George, E. Chendamarai, P. Balasubramanian, 2009, Leukemia & lymphoma.

BCR-ABL1 kinase domain mutation analysis by next generation sequencing detected additional mutations in chronic myeloid leukemia patients with suboptimal response to imatinib

P. Balasubramanian, V. Mathews, V. Veldore, 2021, Leukemia & lymphoma.

Efficient and error-free correction of sickle mutation in human erythroid cells using prime editor-2

P. Balasubramanian, Yukio Nakamura, K. M. Mohankumar, 2022, Frontiers in Genome Editing.

Preferential expansion of human CD34+CD133+CD90+ hematopoietic stem cells enhances gene-modified cell frequency for gene therapy.

K. M. Mohankumar, A. Srivastava, Saravanabhavan Thangavel, 2021, Human gene therapy.

Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies

P. Balasubramanian, K. M. Mohankumar, A. Srivastava, 2022, bioRxiv.

Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines.

P. Balasubramanian, V. Mathews, E. David, 2023, Leukemia research.

Chorionic villous sampling through transvaginal ultrasound approach: A retrospective analysis of 1138 cases

B. Antonisamy, M. Kamath, S. Velayudhan, 2016, The journal of obstetrics and gynaecology research.

Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo

P. Balasubramanian, V. Mathews, Balaji Balakrishnan, 2023, Frontiers in Pharmacology.

Comprehensive laboratory diagnosis of Fanconi anaemia: comparison of cellular and molecular analysis

B. George, G. Joshi, A. Abraham, 2023, Journal of Medical Genetics.

Plasma imatinib levels and ABCB1 polymorphism influences early molecular response and failure-free survival in newly diagnosed chronic phase CML patients

B. George, K. Lakshmi, P. Balasubramanian, 2020, Scientific Reports.

Efficient deletion of microRNAs using CRISPR/Cas9 with dual guide RNAs

P. Balasubramanian, S. Velayudhan, Vasanth Thamodaran, 2024, Frontiers in molecular biosciences.

Special Section on Non-Coding RNA: From Biomarker to Therapeutic Tool Role of Long Non-Coding RNAs in Human-Induced Pluripotent Stem Cells Derived Megakaryocytes: A p53, HOX Antisense Intergenic RNA Myeloid 1, and miR-125b Interaction Study

S. Dahariya, Sanjeev Raghuwanshi, R. Gutti, 2022 .

Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSC) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs.

P. Balasubramanian, A. Abraham, S. Velayudhan, 2024, Cellular signalling.

Inhibition of BCR::ABL1 tyrosine kinase activity Aids in the Generation of Stable Chronic Myeloid Leukemia Induced Pluripotent Stem Cells

D. Babu, P. Balasubramanian, C. Premkumar, 2023, bioRxiv.

Establishment and characterization of CSCRi006-A: an induced pluripotent stem cell line generated from a patient with Diamond-Blackfan Anemia (DBA) carrying ribosomal protein S19 (RPS19) mutation

S. Velayudhan, Vasanth Thamodaran, K. Nandy, 2023, Human Cell.

Generation and characterization of induced pluripotent stem cell line IITGi001-A derived from adult human primary dermal fibroblasts.

C. Premkumar, Rajkumar P. Thummer, S. Velayudhan, 2023, Stem cell research.

Generation of an integration-free iPSC line (CSCRi005-A) from erythroid progenitor cells of a healthy Indian male individual.

A. Srivastava, V. Srivastava, S. P. Bharathan, 2018, Stem cell research.

Efficient gene editing in induced pluripotent stem cells enabled by an inducible adenine base editor with tunable expression

S. Velayudhan, Smitha Ijee, Dhavapriya Palani, 2023, Scientific reports.

Chorionic villous sampling through transvaginal ultrasound approach: A retrospective analysis of 1138 cases

B. Antonisamy, M. Kamath, S. Velayudhan, 2016, The journal of obstetrics and gynaecology research.